Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tenax Therapeutics (TENX) Return on Equity (2016 - 2017)

Historic Return on Equity for Tenax Therapeutics (TENX) over the last 5 years, with Q3 2017 value amounting to 3.2%.

  • Tenax Therapeutics' Return on Equity fell 27600.0% to 3.2% in Q3 2017 from the same period last year, while for Sep 2017 it was 3.2%, marking a year-over-year decrease of 27600.0%. This contributed to the annual value of 1.02% for FY2016, which is N/A changed from last year.
  • As of Q3 2017, Tenax Therapeutics' Return on Equity stood at 3.2%, which was down 27600.0% from 3.05% recorded in Q2 2017.
  • In the past 5 years, Tenax Therapeutics' Return on Equity ranged from a high of 74.34% in Q2 2013 and a low of 121.83% during Q1 2013
  • Its 3-year average for Return on Equity is 8.33%, with a median of 2.78% in 2017.
  • The largest annual percentage gain for Tenax Therapeutics' Return on Equity in the last 5 years was 2313700bps (2013), contrasted with its biggest fall of -1262500bps (2013).
  • Over the past 3 years, Tenax Therapeutics' Return on Equity (Quarter) stood at 74.34% in 2013, then plummeted by -102bps to 1.36% in 2016, then plummeted by -135bps to 3.2% in 2017.
  • Its last three reported values are 3.2% in Q3 2017, 3.05% for Q2 2017, and 2.78% during Q1 2017.